Fundraising Fox
/Companies
Sign in

InjectSense

Emeryville, US · Founded 2014 · Delaware corporation

Find your way into InjectSense

Sign up to find every way you can get introduced to InjectSense

  • Your email: who you already know at InjectSense, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the InjectSense team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Injectsense develops implant-based digital health systems that use semiconductor technology to provide medical staff with continuous long-term monitoring data for therapy management, with an ophthalmology focus including eye-pressure markers. The company combines ultra-low power IC design, telemetry, and miniaturization with medical device and software expertise.

Digital HealthHardwareMedical DevicesSemiconductors

Founders & leadership

EM
Enrique MalaretNamed on SEC filing
ACAriel Cao
Ariel CaoPresident/CEO, co-founder
ZS
Zack ScottNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$13.9M disclosed across 2 rounds · 2017–2019

▶$4.1MraisedApr 2019 · 23 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Enrique MalaretExecutive Officer, Director
  • Ariel CaoExecutive Officer, Director
  • Zack ScottDirector
Offering amount
$8.4M
Amount sold
$4.1M
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.8MraisedOct 2017 · 42 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Enrique MalaretExecutive Officer, Director
  • Ariel CaoExecutive Officer, Director
Offering amount
$9.8M
Amount sold
$9.8M
First sale
Oct 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 6

InfusenseInfuSense develops an electrochemical sensing technology platform that detects analytes at sub-therapeutic levels, delivering sample analysis results within minutes. The portable device is designed to bring laboratory-scale testing capabilities into a handheld form factor.
Senseonics HoldingsSenseonics develops and commercializes Eversense, an implantable continuous glucose monitoring system designed to measure blood sugar levels for up to one year in people with diabetes, offering an alternative to conventional glucose monitors that require more frequent sensor replacement. The company sells its system directly and through distribution partners in the United States and Europe.
CranioSenseCranioSense develops IPASS, a non-invasive medical device that measures intracranial pressure using a forehead patch and handheld device, eliminating the need for invasive skull drilling in traumatic brain injury assessment.
ClearsenseClearsense operates the 1Clearsense Platform, a healthcare data lakehouse that unifies and manages disparate data for health systems and presents it in simplified, actionable views. The company targets health systems to reduce costs, improve operational efficiency, accelerate research and impact care outcomes.
NirsenseNIRSense builds ruggedized, wireless hospital-quality patient monitors that measure tissue oxygen kinetics and other physiological data, including arterial (SpO2) and tissue (StO2) oxygenation, to help clinicians diagnose and treat critical conditions such as cardiogenic shock. Its devices are designed for use in uncontrolled environments including emergency and intensive care settings and military front lines.
SisenseSisense provides embedded analytics software that enables teams to integrate data visualization and insights into business applications. The platform serves product development teams and enterprises seeking to build data-driven features into their software products.

Companies working in the same space as InjectSense.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$1.6M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does InjectSense do?
Injectsense develops implant-based digital health systems that use semiconductor technology to provide medical staff with continuous long-term monitoring data for therapy management, with an ophthalmology focus including eye-pressure markers. The company combines ultra-low power IC design, telemetry, and miniaturization with medical device and software expertise.
How much funding has InjectSense raised?
InjectSense has disclosed $13.9M raised across 2 rounds.
Where is InjectSense headquartered?
InjectSense is headquartered in Emeryville, US.